ASP3082 (Astellas Pharma) is a PROTAC that binds to KRAS G12D and E3 ubiquitin ligase, leading to selective KRAS G12D protein degradation and growth inhibitory activity in KRAS G12D-mutated cancer cells while sparing KRAS wild-type cancer cells [41]. Here, KRAS is linked to cancer.